A Maximum Flow-Based Approach to Prioritize Drugs for Drug Repurposing of Chronic Diseases
The discovery of new drugs is required in the time of global aging and increasing populations. Traditional drug development strategies are expensive, time-consuming, and have high risks. Thus, drug repurposing, which treats new/other diseases using existing drugs, has become a very admired tactic. I...
Guardado en:
Autores principales: | Md. Mohaiminul Islam, Yang Wang, Pingzhao Hu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c03932404a84e9f8e1fc4635c6bc46e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Network-Guided Discovery of Influenza Virus Replication Host Factors
por: Emily E. Ackerman, et al.
Publicado: (2018) -
Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Simona Rapposelli, et al.
Publicado: (2021) -
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
por: José Manuel Ezquerra-Aznárez, et al.
Publicado: (2021) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Joana M. O. Santos, et al.
Publicado: (2021) -
A Database of Drug Repurposing Clinical Trials in Oncology
por: Pan Pantziarka, et al.
Publicado: (2021)